| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 36.251 | 40.222 | 43.784 | 46.020 | 75.582 | 62.371 | 66.550 | 46.166 | 58.419 | 37.760 |
| Total Income - EUR | 36.251 | 40.222 | 43.784 | 46.020 | 75.583 | 63.408 | 66.551 | 46.169 | 58.425 | 37.765 |
| Total Expenses - EUR | 7.951 | 8.411 | 7.476 | 11.013 | 44.104 | 41.564 | 46.772 | 37.556 | 37.337 | 18.605 |
| Gross Profit/Loss - EUR | 28.300 | 31.811 | 36.307 | 35.007 | 31.479 | 21.844 | 19.779 | 8.612 | 21.088 | 19.160 |
| Net Profit/Loss - EUR | 27.212 | 30.605 | 34.994 | 33.627 | 30.723 | 21.364 | 19.127 | 8.220 | 20.562 | 18.174 |
| Employees | 0 | 2 | 2 | 2 | 4 | 4 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Endomedplus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 94.962 | 106.165 | 106.054 | 136.796 | 139.666 | 137.599 | 137.671 | 126.963 | 120.849 | 132.821 |
| Inventories | 0 | 0 | 0 | 0 | 77.478 | 130.811 | 127.911 | 0 | 0 | 0 |
| Receivables | 77.558 | 105.494 | 99.913 | 128.531 | 0 | 0 | 0 | 125.164 | 119.892 | 119.407 |
| Cash | 17.405 | 670 | 6.141 | 8.266 | 62.188 | 6.788 | 9.761 | 1.799 | 957 | 13.414 |
| Shareholders Funds | 94.526 | 105.461 | 104.192 | 135.907 | 64.178 | 76.339 | 93.134 | 101.643 | 117.502 | 130.431 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 436 | 703 | 1.861 | 889 | 75.488 | 61.260 | 44.538 | 25.320 | 3.348 | 2.390 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endomedplus S.r.l.